Stephen Forman, MD
Enriched profileDirector, Hematologic Malignancies Research Institute; Director, Cellular Immunotherapy Center; Director, T Cell Therapeutics Research Laboratory; Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope (transitioned out of Department Chair role in Feb 2020 to Eileen P. Smith, MD, who now holds the Francis and Kathleen McNamara Distinguished Chair) · City of Hope Comprehensive Cancer Center
Stephen Forman is Director, Hematologic Malignancies Research Institute; Director, Cellular Immunotherapy Center; Director, T Cell Therapeutics Research Laboratory; Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope (transitioned out of Department Chair role in Feb 2020 to Eileen P. Smith, MD, who now holds the Francis and Kathleen McNamara Distinguished Chair) at City of Hope Comprehensive Cancer Center. OpenAlex indexes 1,782 publications with 60,700 citations (h-index 128); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology profiles in the findmyKOL directory. Clarivate lists Stephen Forman as a Highly Cited Researcher (Cross-Field, 2025).
Data verified 14 Sept 2026
Overview
Updated 14 Oct 2026
Stephen J. Forman is Director, Hematologic Malignancies Research Institute at City of Hope Comprehensive Cancer Center / City of Hope National Medical Center, Duarte, CA. The public record shows 1,782 publications with 60,700 citations (h-index 128), centered on CAR-T cell therapy research, Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia research. It also documents an investigator role on 4 registered clinical trials, 9 NIH-funded awards (1985–2026).
- Most recent indexed publication: 2026 · Cancer research
- Top research focus: CAR-T cell therapy research
- 4 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 36 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 627.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Public comments submitted to the CIRM (California Institute for Regenerative Medicine) Board (January 27, 2026)
advocating on behalf of City of Hope, UCLA, Swedish Cancer Institute …
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cirm.ca.gov ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Sponsor: University of Michigan Rogel Cancer Center
- Blood and Marrow Transplant Clinical Research Network
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Industry payments
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment
- ABBVIE INC.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
41%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor41%Acyclovir100%Part D<11 patientsCancer & immunology
30.8%Aromatase Inhibitor30.8%Anastrozole100%Part D<11 patientsMetabolism & gastrointestinal
28.2%Corticosteroid28.2%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
9 NIH research awards on record, funded 1985–2026 per NIH RePORTER. The latest:
- Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
Beckman Research Institute/city of Hope
FY2026$710,482R01CA266611 - Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
Beckman Research Institute/city of Hope
FY2025$710,483R01CA266611 - Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
Beckman Research Institute/city of Hope
FY2024$364,612R01CA266611
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Whole-protein screening and multi-modal profiling of antigen-specific CD4(+) T cells at single-cell resolution.
Nature communications
Article2026 - Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy.
Nature communications
Article2026 - Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis.
Bone marrow transplantation
Article2026 - Smoking cessation among blood or marrow transplant Survivors: a BMTSS Report.
Bone marrow transplantation
Letter2025
Most-cited works
by citation count (OpenAlex)Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/stephen-forman-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/dr-stephen-forman-9692b928
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Stephen-Forman-2191469460
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - ResearchGate
researchgate.net/scientific-contributions/Stephen-J-Forman-2259846958
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/cityofhope/posts/congratulations-to-our-own-stephen-j-forman-md-director-of-the-hematologic-malig/625603936271688
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Facebook
facebook.com/cityofhope/videos/city-of-hope-ash20-preview-stephen-j-forman-md/201326108281368
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Instagram
instagram.com/cityofhope/p/Cr1RNI3JWei
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
ascopost.com/issues/june-3-2022-narratives-special-issue/a-leader-in-oncology-balances-philosophy-medicine-and-humility
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - Other
modernhealthcare.com/content-studio/executive-conversation/city-of-hope-50-years-bone-marrow-transplant-forman
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →modernhealthcare.com ↗ - Other
onclive.com/view/knocking-expectations-out-of-the-park-in-the-search-for-a-cure
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - X / Twitter
x.com/cityofhope/status/1101613701004775424
- YouTube
youtube.com/shorts/-N5RxMR8ZBk
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - X / Twitter
City of Hope official X (Twitter) post announcing his DKMS Mechtild Harf Science Award and E. Donnall Thomas honors
- LinkedIn
LinkedIn profile listing him under City of Hope (auth-walled; corroborated only via SERP snippet, not independently verified content)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- M.D.
University of Southern California, Los Angeles
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cirm.ca.gov ↗
- Former Chair (~30+ years, transitioned February 2020)
Department of Hematology & Hematopoietic Cell Transplantation, City of Hope; succeeded by Eileen P. Smith, MD
2020verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - Director
Hematologic Malignancies Research Institute, City of Hope
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cirm.ca.gov ↗ - Director
Cellular Immunotherapy Center, City of Hope (Co-Director: Christine Brown, Ph.D.)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cirm.ca.gov ↗ - Director
T Cell Therapeutics Research Laboratories, City of Hope
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Co-editor
"Thomas' Hematopoietic Cell Transplantation" (definitive HCT textbook, with Karl Blume and E. Donnall Thomas)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancercenter.com ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- Cross-Field2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- 2019 DKMS Mechtild Harf Science Award
presented in Frankfurt, Germany, for outstanding achievements in cancer immunology, hematology, stem cell transplantation, and CAR T-cell therapy
2019verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →businesswire.com ↗ - E. Donnall Thomas Lecture/Award
delivered at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR, Houston
2019verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →businesswire.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- Fellow
American College of Physicians (F.A.C.P.)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
Secondary affiliations
appointments beyond the home institution- Toni Stephenson Lymphoma Center
City of Hope (translational/clinical research involvement)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancercenter.com ↗ - Judy and Bernard Briskin Center for Multiple Myeloma Research
City of Hope (translational/clinical research involvement)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cirm.ca.gov ↗ - Gehr Family Center for Leukemia Research
City of Hope (translational/clinical research involvement)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cirm.ca.gov ↗ - Board of Visitors and Governors
St. John's College, Annapolis, MD (alma mater)
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →modernhealthcare.com ↗
- City of Hope appearance on Charlie Rose (PBS)
discussing advances in cancer prevention, detection, and treatment, alongside Robert Stone and Steven Rosen
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →charlierose.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Guido Marcucci, MD
City of Hope Comprehensive Cancer Center
Marwan Fakih, MD
City of Hope Comprehensive Cancer Center
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Jorge Cortes, MD
University of Alabama at Birmingham (UAB)
Ayalew Tefferi, MD
Mayo Clinic
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center